Nucleic Acid Labeling Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 7.50 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Nucleic Acid Labeling Market Analysis
Personalized medicine aims to provide tailor-made therapies to individual patients, depending on the molecular basis of disease, which has become popular in recent years. Healthcare technology, genomics involving nucleic acid labeling technology, connected devices, big data analytics, and artificial intelligence are generating vast amounts of health data and insights. This is enabling healthcare providers to offer better and faster diagnoses and make more informed treatment decisions. Rising demand for personalized medicine has created tremendous opportunities in the field of genetic medicine, and in order to exploit these opportunities, novel technologies must be developed, which, in turn, has resulted in the rapid expansion of the market. Therefore, increasing focus on personalized medicine and patient-centered approach is driving the growth of the nucleic acid labeling market.
Nucleic Acid Labeling Market Trends
This section covers the major market trends shaping the Nucleic Acid Labeling Market according to our research experts:
Biotin Based Segment is Expected to Show Better Growth Over the Forecast Period
Based on label type, the market is segmented into biotin-based, fluorescent, radioactive and other label types. Non-radioactively labeled probes, such as biotin-based probes have several advantages over radioactive probes, such as increased stability and their non-hazardous nature. The biotin-based labels use non-toxic materials and have faster detection rates than radioactive probes. Furthermore, owing to their long half-life and high stability, biotin-based probes can be prepared in bulk and stored at -20°C for repeated uses. Furthermore, there have been several advancements in biotin-based techniques, such as the addition of long tails of biotinylated nucleotides through enzymatic methods to counter the technique’s limitations. Pertaining to these advancements, the biotin-based label segment is expected to show better growth during the forecast period.
North America is Expected to Dominate the Nucleic Acid Labeling Market
The nucleic acid labeling market dominates the North America region due to the increasing prevalence of chronic diseases, such as cancer, aging population, growing demand for targeted and personalized medicine, and favorable government initiatives. In recent years, several government initiatives have been launched, which is supplementing the growth of the nucleic acid labeling market in the United States. For instance, in 2015, the Precision Medicine Initiative was introduced to revolutionize the treatment of chronic diseases, which has accelerated the growth of the nucleic acid labeling and its acceptance as well as adoption in the region.
Nucleic Acid Labeling Industry Overview
The global players into the nucleic acid labeling market are Enzo Biochem Inc., GE Healthcare, Marker Gene Technologies Inc., Merck KGaA, New England Biolabs Inc., PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific and Vector Laboratories Inc.
Nucleic Acid Labeling Market Leaders
-
GE Healthcare
-
Merck KGaA
-
PerkinElmer Inc.
-
Promega Corporation
-
Thermo Fisher Scientific
*Disclaimer: Major Players sorted in no particular order
Nucleic Acid Labeling Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Deliverables
- 1.2 Study Assumptions
- 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising Genomic and Enzymology Research
- 4.2.2 Advancements in Tools for Synthetic Genome Design
- 4.2.3 Growing Demand for Personalized Medicine
-
4.3 Market Restraints
- 4.3.1 Lack of Skilled Professionals
- 4.3.2 High Cost and Complexity of Techniques
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 By Label Type
- 5.1.1 Biotin-based
- 5.1.2 Fluorescent
- 5.1.3 Radioactive
- 5.1.4 Other Label Types
-
5.2 By Application
- 5.2.1 Microarray
- 5.2.2 DNA Sequencing
- 5.2.3 In situ Hybridization
- 5.2.4 Polymerase Chain Reaction
- 5.2.5 Other Applications
-
5.3 By End User
- 5.3.1 Hospitals/Clinics
- 5.3.2 Diagnostic Centers
- 5.3.3 Others
-
5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle-East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle-East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Enzo Biochem Inc.
- 6.1.2 GE Healthcare
- 6.1.3 Marker Gene Technologies Inc.
- 6.1.4 Merck KGaA
- 6.1.5 New England Biolabs Inc.
- 6.1.6 PerkinElmer Inc.
- 6.1.7 Promega Corporation
- 6.1.8 Thermo Fisher Scientific
- 6.1.9 Vector Laboratories Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityNucleic Acid Labeling Industry Segmentation
As per the scope of the report, nucleic acids are complex biomolecules that are responsible for the transfer of genetic information in all living organisms. Nucleic acid labeling is a procedure in which nucleic acids are modified or attached with tags that enable their detection or purification.
| By Label Type | Biotin-based | |
| Fluorescent | ||
| Radioactive | ||
| Other Label Types | ||
| By Application | Microarray | |
| DNA Sequencing | ||
| In situ Hybridization | ||
| Polymerase Chain Reaction | ||
| Other Applications | ||
| By End User | Hospitals/Clinics | |
| Diagnostic Centers | ||
| Others | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle-East and Africa | GCC |
| South Africa | ||
| Rest of Middle-East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Nucleic Acid Labeling Market Research FAQs
What is the current Nucleic Acid Labeling Market size?
The Nucleic Acid Labeling Market is projected to register a CAGR of 7.5% during the forecast period (2024-2029)
Who are the key players in Nucleic Acid Labeling Market?
GE Healthcare, Merck KGaA, PerkinElmer Inc., Promega Corporation and Thermo Fisher Scientific are the major companies operating in the Nucleic Acid Labeling Market.
Which is the fastest growing region in Nucleic Acid Labeling Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Nucleic Acid Labeling Market?
In 2024, the North America accounts for the largest market share in Nucleic Acid Labeling Market.
What years does this Nucleic Acid Labeling Market cover?
The report covers the Nucleic Acid Labeling Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Nucleic Acid Labeling Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Nucleic Acid Labeling Industry Report
Statistics for the 2024 Nucleic Acid Labeling market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Nucleic Acid Labeling analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
